Health-related quality of life in the general Norwegian population assessed by the European Organization for Research and Treatment of Cancer Core Quality-of-Life Questionnaire: The QLQ=C30 (+ 3)

Marianne J. Hjermstad*, Peter M. Fayers, Kristin Bjordal, Stein Kaasa

*Corresponding author for this work

Research output: Contribution to journalArticle

261 Citations (Scopus)

Abstract

Purpose: To obtain reference data on health-related quality of life (HRQOL) for the functional and symptom scales and single items of the European Organization for Research and Treatment of Cancer Core Quality-of- Life Questionnaire (EORTC QLQ-C30 [+ 3]) in a representative sample of the Norwegian general population. Patients and Methods: A randomly selected sample of 3,000 people from the Norwegian population, aged 18 to 93 years, who represent geographic diversity, took part in this postal survey. The EORTC QLQ-C30 (+ 3) and a questionnaire about demographic data and health were sent mail. A new questionnaire package was sent as a reminder after 3 weeks. Results: The survey yielded a high response rate with 1,965 of 2,892 eligible persons responding (68%). There was a low amount of missing data (1.8%). Internal consistency was highly satisfactory and yielded Cronbach's alpha coefficients greater than 0.70 for all but two functional scales and one symptom scale. The sensitivity of the questionnaire was shown the excellent discrimination between age and sex groups. Clinical validity was shown the distinct differences according to age and sociodemographic characteristics. Women reported lower functional status and global quality of life (mean scale scores from 71.7 to 91.0) than men (mean scale scores from 75.4 to 94.4), and also more symptoms and problems. This was remarkably consistent across age groups, as was a decline in functional status with an increase in age. Conclusion: This is the first study that presented reference data from the EORTC QLQ-C30 (+ 3) in a sample from a general population and seems to provide valid measures of HRQOL within different age groups. The results may serve as a guideline for clinicians when interpreting HRQOL in their own groups of patients, and contributes to a better understanding of the significance of mean scores and their clinical relevance.

Original languageEnglish
Pages (from-to)1188-1196
Number of pages9
JournalJournal of Clinical Oncology
Volume16
Issue number3
DOIs
Publication statusPublished - 1 Mar 1998

Fingerprint

Quality of Life
Organizations
Research
Population
Neoplasms
Age Groups
Therapeutics
Sexism
Postal Service
Surveys and Questionnaires
Demography
Guidelines
Health

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

@article{1a0a564acff74fd7acf73f0556a2a0c9,
title = "Health-related quality of life in the general Norwegian population assessed by the European Organization for Research and Treatment of Cancer Core Quality-of-Life Questionnaire: The QLQ=C30 (+ 3)",
abstract = "Purpose: To obtain reference data on health-related quality of life (HRQOL) for the functional and symptom scales and single items of the European Organization for Research and Treatment of Cancer Core Quality-of- Life Questionnaire (EORTC QLQ-C30 [+ 3]) in a representative sample of the Norwegian general population. Patients and Methods: A randomly selected sample of 3,000 people from the Norwegian population, aged 18 to 93 years, who represent geographic diversity, took part in this postal survey. The EORTC QLQ-C30 (+ 3) and a questionnaire about demographic data and health were sent mail. A new questionnaire package was sent as a reminder after 3 weeks. Results: The survey yielded a high response rate with 1,965 of 2,892 eligible persons responding (68{\%}). There was a low amount of missing data (1.8{\%}). Internal consistency was highly satisfactory and yielded Cronbach's alpha coefficients greater than 0.70 for all but two functional scales and one symptom scale. The sensitivity of the questionnaire was shown the excellent discrimination between age and sex groups. Clinical validity was shown the distinct differences according to age and sociodemographic characteristics. Women reported lower functional status and global quality of life (mean scale scores from 71.7 to 91.0) than men (mean scale scores from 75.4 to 94.4), and also more symptoms and problems. This was remarkably consistent across age groups, as was a decline in functional status with an increase in age. Conclusion: This is the first study that presented reference data from the EORTC QLQ-C30 (+ 3) in a sample from a general population and seems to provide valid measures of HRQOL within different age groups. The results may serve as a guideline for clinicians when interpreting HRQOL in their own groups of patients, and contributes to a better understanding of the significance of mean scores and their clinical relevance.",
author = "Hjermstad, {Marianne J.} and Fayers, {Peter M.} and Kristin Bjordal and Stein Kaasa",
year = "1998",
month = "3",
day = "1",
doi = "10.1200/JCO.1998.16.3.1188",
language = "English",
volume = "16",
pages = "1188--1196",
journal = "Journal of Clinical Oncology",
issn = "0732-183X",
publisher = "American Society of Clinical Oncology",
number = "3",

}

TY - JOUR

T1 - Health-related quality of life in the general Norwegian population assessed by the European Organization for Research and Treatment of Cancer Core Quality-of-Life Questionnaire

T2 - The QLQ=C30 (+ 3)

AU - Hjermstad, Marianne J.

AU - Fayers, Peter M.

AU - Bjordal, Kristin

AU - Kaasa, Stein

PY - 1998/3/1

Y1 - 1998/3/1

N2 - Purpose: To obtain reference data on health-related quality of life (HRQOL) for the functional and symptom scales and single items of the European Organization for Research and Treatment of Cancer Core Quality-of- Life Questionnaire (EORTC QLQ-C30 [+ 3]) in a representative sample of the Norwegian general population. Patients and Methods: A randomly selected sample of 3,000 people from the Norwegian population, aged 18 to 93 years, who represent geographic diversity, took part in this postal survey. The EORTC QLQ-C30 (+ 3) and a questionnaire about demographic data and health were sent mail. A new questionnaire package was sent as a reminder after 3 weeks. Results: The survey yielded a high response rate with 1,965 of 2,892 eligible persons responding (68%). There was a low amount of missing data (1.8%). Internal consistency was highly satisfactory and yielded Cronbach's alpha coefficients greater than 0.70 for all but two functional scales and one symptom scale. The sensitivity of the questionnaire was shown the excellent discrimination between age and sex groups. Clinical validity was shown the distinct differences according to age and sociodemographic characteristics. Women reported lower functional status and global quality of life (mean scale scores from 71.7 to 91.0) than men (mean scale scores from 75.4 to 94.4), and also more symptoms and problems. This was remarkably consistent across age groups, as was a decline in functional status with an increase in age. Conclusion: This is the first study that presented reference data from the EORTC QLQ-C30 (+ 3) in a sample from a general population and seems to provide valid measures of HRQOL within different age groups. The results may serve as a guideline for clinicians when interpreting HRQOL in their own groups of patients, and contributes to a better understanding of the significance of mean scores and their clinical relevance.

AB - Purpose: To obtain reference data on health-related quality of life (HRQOL) for the functional and symptom scales and single items of the European Organization for Research and Treatment of Cancer Core Quality-of- Life Questionnaire (EORTC QLQ-C30 [+ 3]) in a representative sample of the Norwegian general population. Patients and Methods: A randomly selected sample of 3,000 people from the Norwegian population, aged 18 to 93 years, who represent geographic diversity, took part in this postal survey. The EORTC QLQ-C30 (+ 3) and a questionnaire about demographic data and health were sent mail. A new questionnaire package was sent as a reminder after 3 weeks. Results: The survey yielded a high response rate with 1,965 of 2,892 eligible persons responding (68%). There was a low amount of missing data (1.8%). Internal consistency was highly satisfactory and yielded Cronbach's alpha coefficients greater than 0.70 for all but two functional scales and one symptom scale. The sensitivity of the questionnaire was shown the excellent discrimination between age and sex groups. Clinical validity was shown the distinct differences according to age and sociodemographic characteristics. Women reported lower functional status and global quality of life (mean scale scores from 71.7 to 91.0) than men (mean scale scores from 75.4 to 94.4), and also more symptoms and problems. This was remarkably consistent across age groups, as was a decline in functional status with an increase in age. Conclusion: This is the first study that presented reference data from the EORTC QLQ-C30 (+ 3) in a sample from a general population and seems to provide valid measures of HRQOL within different age groups. The results may serve as a guideline for clinicians when interpreting HRQOL in their own groups of patients, and contributes to a better understanding of the significance of mean scores and their clinical relevance.

UR - http://www.scopus.com/inward/record.url?scp=0031910492&partnerID=8YFLogxK

U2 - 10.1200/JCO.1998.16.3.1188

DO - 10.1200/JCO.1998.16.3.1188

M3 - Article

AN - SCOPUS:0031910492

VL - 16

SP - 1188

EP - 1196

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

SN - 0732-183X

IS - 3

ER -